Pharmaceutical industry attempting to undermine access to affordable medicines

South Africa’s eligibility for ongoing inclusion in the African Growth and Opportunity Act is being used as a bargaining chip in pressure by the pharmaceutical industry to get the country to backtrack on intellectual property law reforms aimed at promoting access to more affordable medicines, charged several South African advocacy and human rights groups, reports Times Live, a South African newspaper.